{"disease":{"id":"polymorphic-light-eruption","name":"polymorphic light eruption"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04704713","title":"Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Clinuvel Pharmaceuticals Limited","has_results":true},{"nct_id":"NCT04985526","title":"Skin Microbiome and Polymorphic Light Eruption","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT05320315","title":"Protective Effect Assessment of Foto Ultra Isdin Solar Allergy Fusion Fluid on the UVA Induced PLE","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Centre de Pharmacologie Clinique Applique a la Dermatologie","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}